Skip to main content

Advertisement

SpringerLink
Log in

Stereotactic radiotherapy as primary definitive or postoperative treatment of intracranial meningioma of WHO grade II and III leads to better disease control than stereotactic radiotherapy of recurrent meningioma

  • Clinical Study
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

The aim of this study was to evaluate long-term clinical outcome, prognostic factors and quality of life after adjuvant or definitive fractionated stereotactic radiotherapy (SRT) of meningioma WHO grade II and III or at recurrence. 131 patients with 138 meningioma (64 WHO grade II, 16 WHO grade III, 58 without histology) of the skull base, falx and convexity were treated between 01/2002 and 01/2015 at the Erlangen University Hospital by fractionated stereotactic radiotherapy (SRT) as primary treatment (adjuvant or definitive) and at recurrence. 53% (n = 53) lesions of patients with primary tumour received postoperative SRT and 47% (n = 47) as definitive treatment (without surgery). All 38 lesions (100%) of recurrent meningioma underwent surgery followed by SRT. SRT was mostly given in 28, 30 or 25 fractions to a median dose of 54.0 Gy in the reference point. Progression-free-survival at 8 years for patients with meningioma at primary treatment were significantly better with 100% for patients with definitive SRT (p = 0.008) or 85% for patients with adjuvant SRT (p = 0.009) compared to 42% after treatment (surgery + SRT) of recurrence. Progression-free-survival at 8 years for patients with SRT as adjuvant treatment after gross total resection of WHO grade II meningioma were significantly better at 83% (p = 0.016) compared to 46% after adjuvant SRT of recurrence. In 31% of patients after primary treatment and in 38.5% after recurrence treatment an improvement of pain symptoms was achieved. The favourable prognostic factor for better PFS at recurrence treatment was tumor location (skull base or convexity better compared to the falx). Postoperative SRT of WHO grade II meningioma after gross total resection (GTR) can effectively reduce recurrence risk.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Maranzano E, Draghini L, Casale M, Arcidiacono F, Anselmo P, Trippa F, Giorgi C (2015) Long-term outcome of moderate hypofractionated stereotactic radiotherapy for meningiomas. Strahlentherapie und Onkologie 191:953–960. doi:10.1007/s00066-015-0915-2

    Article  PubMed  Google Scholar 

  2. Rogers L, Barani I, Chamberlain M, Kaley TJ, McDermott M, Raizer J, Schiff D, Weber DC, Wen PY, Vogelbaum MA (2015) Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review. J Neurosurg 122:4–23. doi:10.3171/2014.7.JNS131644

    Article  PubMed  PubMed Central  Google Scholar 

  3. Lee S, Kwon do H, Kim CJ, Kim JH (2016) Long-term outcomes following Gamma Knife radiosurgery for small, newly diagnosed meningiomas. Clin Neurol Neurosurg 142:1–7. doi:10.1016/j.clineuro.2016.01.009

    Article  CAS  PubMed  Google Scholar 

  4. Stieler F, Wenz F, Abo-Madyan Y, Schweizer B, Polednik M, Herskind C, Giordano FA, Mai S (2016) Adaptive fractionated stereotactic Gamma Knife radiotherapy of meningioma using integrated stereotactic cone-beam-CT and adaptive re-planning (a-gkFSRT). Strahlentherapie und Onkologie. doi:10.1007/s00066-016-1008-6

    Google Scholar 

  5. Hundsberger T, Surbeck W, Hader C, Putora PM, Conen K, Roelcke U (2016) Meningioma: management of the most common brain tumour. Praxis 105:445–451. doi:10.1024/1661-8157/a002320

    Article  PubMed  Google Scholar 

  6. Sun SQ, Cai C, Murphy RK, DeWees T, Dacey RG, Grubb RL, Rich KM, Zipfel GJ, Dowling JL, Leuthardt EC, Simpson JR, Robinson CG, Chicoine MR, Perrin RJ, Huang J, Kim AH (2016) Radiation therapy for residual or recurrent atypical meningioma: the effects of modality, timing, and tumor pathology on long-term outcomes. Neurosurgery 79:23–32. doi:10.1227/NEU.0000000000001160

    Article  PubMed  Google Scholar 

  7. Biau J, Khalil T, Verrelle P, Lemaire JJ (2015) Fractionated radiotherapy and radiosurgery of intracranial meningiomas. Neurochirurgie. doi:10.1016/j.neuchi.2014.10.112

    PubMed  Google Scholar 

  8. Combs SE, Welzel T, Kessel K, Habermehl D, Rieken S, Schramm O, Debus J (2013) Hearing preservation after radiotherapy for vestibular schwannomas is comparable to hearing deterioration in healthy adults and is accompanied by local tumor control and a highly preserved quality of life (QOL) as patients’ self-reported outcome. Radiother Oncol 106:175–180. doi:10.1016/j.radonc.2012.12.004

    Article  PubMed  Google Scholar 

  9. Glaholm J, Bloom HJ, Crow JH (1990) The role of radiotherapy in the management of intracranial meningiomas: the Royal Marsden Hospital experience with 186 patients. Int J Radiat Oncol Biol Phys 18:755–761

    Article  CAS  PubMed  Google Scholar 

  10. Hug EB, Devries A, Thornton AF, Munzenride JE, Pardo FS, Hedley-Whyte ET, Bussiere MR, Ojemann R (2000) Management of atypical and malignant meningiomas: role of high-dose, 3D-conformal radiation therapy. J Neurooncol 48:151–160

    Article  CAS  PubMed  Google Scholar 

  11. Aghi MK, Carter BS, Cosgrove GR, Ojemann RG, Amin-Hanjani S, Martuza RL, Curry WT, Jr., Barker FG, 2nd (2009) Long-term recurrence rates of atypical meningiomas after gross total resection with or without postoperative adjuvant radiation. Neurosurgery 64: 56–60. doi:10.1227/01.NEU.0000330399.55586.63 (discussion 60)

    Article  PubMed  Google Scholar 

  12. Mair R, Morris K, Scott I, Carroll TA (2011) Radiotherapy for atypical meningiomas. J Neurosurg 115:811–819. doi:10.3171/2011.5.JNS11112

    Article  PubMed  Google Scholar 

  13. Simon M, Bostrom J, Koch P, Schramm J (2006) Interinstitutional variance of postoperative radiotherapy and follow up for meningiomas in Germany: impact of changes of the WHO classification. J Neurol Neurosurg Psychiatry 77:767–773. doi:10.1136/jnnp.2005.077974

    Article  CAS  PubMed  Google Scholar 

  14. Champeaux C, Wilson E, Shieff C, Khan AA, Thorne L (2016) WHO grade II meningioma: a retrospective study for outcome and prognostic factor assessment. J Neurooncol 129:337–345. doi:10.1007/s11060-016-2181-2

    Article  PubMed  Google Scholar 

  15. Wang C, Kaprealian TB, Suh JH, Kubicky CD, Ciporen JN, Chen Y, Jaboin JJ (2017) Overall survival benefit associated with adjuvant radiotherapy in WHO grade II meningioma. Neuro Oncol. doi:10.1093/neuonc/nox007

    Google Scholar 

  16. El-Khatib M, El Majdoub F, Hunsche S, Hoevels M, Kocher M, Sturm V, Maarouf M (2015) Stereotactic LINAC radiosurgery for the treatment of typical intracranial meningiomas. Efficacy and safety after a follow-up of over 12 years. Strahlentherapie und Onkologie 191:921–927 doi:10.1007/s00066-015-0880-9

    Article  PubMed  Google Scholar 

  17. Kaul D, Budach V, Wurm R, Gruen A, Graaf L, Habbel P, Badakhshi H (2014) Linac-based stereotactic radiotherapy and radiosurgery in patients with meningioma. Radiat Oncol 9:78. doi:10.1186/1748-717X-9-78

    Article  PubMed  PubMed Central  Google Scholar 

  18. Combs SE, Welzel T, Schulz-Ertner D, Huber PE, Debus J (2010) Differences in clinical results after LINAC-based single-dose radiosurgery versus fractionated stereotactic radiotherapy for patients with vestibular schwannomas. Int J Radiat Oncol Biol Phys 76:193–200. doi:10.1016/j.ijrobp.2009.01.064

    Article  PubMed  Google Scholar 

  19. World Medical A (2013) World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. Jama 310:2191–2194. doi:10.1001/jama.2013.281053

    Article  Google Scholar 

  20. E3 IT ICH Topic E3 (1996) Note for Guidance on Structure and Content of Clinical Study Reports (CPMP/ICH/137/95)

  21. Champeaux C, Dunn L (2016) World Health Organization grade II meningioma. A 10-year retrospective study for recurrence and prognostic factor assessment. World Neurosurg doi:10.1016/j.wneu.2016.01.055

    Google Scholar 

  22. Zaher A, Mattar MA, Zayed DH, Ellatif RA, Ashamallah SA (2013) Atypical meningioma: a study of prognostic factors. World Neurosurg 80:549–553. doi:10.1016/j.wneu.2013.07.001

    Article  PubMed  Google Scholar 

  23. Aizer AA, Arvold ND, Catalano P, Claus EB, Golby AJ, Johnson MD, Al-Mefty O, Wen PY, Reardon DA, Lee EQ, Nayak L, Rinne ML, Beroukhim R, Weiss SE, Ramkissoon SH, Abedalthagafi M, Santagata S, Dunn IF, Alexander BM (2014) Adjuvant radiation therapy, local recurrence, and the need for salvage therapy in atypical meningioma. Neuro Oncol 16:1547–1553. doi:10.1093/neuonc/nou098

    Article  PubMed  PubMed Central  Google Scholar 

  24. Komotar RJ, Iorgulescu JB, Raper DM, Holland EC, Beal K, Bilsky MH, Brennan CW, Tabar V, Sherman JH, Yamada Y, Gutin PH (2012) The role of radiotherapy following gross-total resection of atypical meningiomas. J Neurosurg 117:679–686. doi:10.3171/2012.7.JNS112113

    Article  PubMed  Google Scholar 

  25. Sun SQ, Kim AH, Cai C, Murphy RK, DeWees T, Sylvester P, Dacey RG, Grubb RL, Rich KM, Zipfel GJ, Dowling JL, Leuthardt EC, Leonard JR, Evans J, Simpson JR, Robinson CG, Perrin RJ, Huang J, Chicoine MR (2014) Management of atypical cranial meningiomas, part 1: predictors of recurrence and the role of adjuvant radiation after gross total resection. Neurosurgery 75:347–354. doi:10.1227/NEU.0000000000000461 (discussion 354–345; quiz 355)

    Article  PubMed  Google Scholar 

  26. Jenkinson MD, Weber DC, Haylock BJ, Mallucci CL, Zakaria R, Javadpour M (2015) Atypical meningoma: current management dilemmas and prospective clinical trials. J Neurooncol 121:1–7. doi:10.1007/s11060-014-1620-1

    Article  CAS  PubMed  Google Scholar 

  27. Cain SA, Smoll NR, Van Heerden J, Tsui A, Drummond KJ (2015) Atypical and malignant meningiomas: Considerations for treatment and efficacy of radiotherapy. J Clin Neurosci 22:1742–1748. doi:10.1016/j.jocn.2015.03.054

    Article  PubMed  Google Scholar 

  28. Rogers L, Zhang P, Vogelbaum MA, Perry A, Ashby L, Modi J, Alleman A, Galvin JM, Brachman D, Jenrette JM, DeGroot J, Bovi JA, Werner-Wasik M, Knisely JPS, Mehta MP (2015) Intermediate-risk meningioma: initial outcomes from NRG oncology/RTOG-0539. Int J Radiat Oncol Biol Phys 93:S139–S140. doi:10.1016/j.ijrobp.2015.07.331

    Article  Google Scholar 

  29. Hammouche S, Clark S, Wong AH, Eldridge P, Farah JO (2014) Long-term survival analysis of atypical meningiomas: survival rates, prognostic factors, operative and radiotherapy treatment. Acta Neurochir 156:1475–1481. doi:10.1007/s00701-014-2156-z

    Article  PubMed  Google Scholar 

  30. Hardesty DA, Wolf AB, Brachman DG, McBride HL, Youssef E, Nakaji P, Porter RW, Smith KA, Spetzler RF, Sanai N (2013) The impact of adjuvant stereotactic radiosurgery on atypical meningioma recurrence following aggressive microsurgical resection. J Neurosurg 119:475–481. doi:10.3171/2012.12.JNS12414

    Article  PubMed  Google Scholar 

  31. Stessin AM, Schwartz A, Judanin G, Pannullo SC, Boockvar JA, Schwartz TH, Stieg PE, Wernicke AG (2012) Does adjuvant external-beam radiotherapy improve outcomes for nonbenign meningiomas? A surveillance, epidemiology, and end results (SEER)-based analysis. J Neurosurg 117:669–675. doi:10.3171/2012.7.JNS111439

    Article  PubMed  Google Scholar 

  32. Piscevic I, Villa A, Milicevic M, Ilic R, Nikitovic M, Cavallo LM, Grujicic D (2015) The influence of adjuvant radiotherapy in atypical and anaplastic meningiomas: a series of 88 patients in a single institution. World Neurosurg 83:987–995. doi:10.1016/j.wneu.2015.02.021

    Article  PubMed  Google Scholar 

  33. Ferraro DJ, Funk RK, Blackett JW, Ju MR, DeWees TA, Chicoine MR, Dowling JL, Rich KM, Drzymala RE, Zoberi I, Simpson JR, Jaboin JJ (2014) A retrospective analysis of survival and prognostic factors after stereotactic radiosurgery for aggressive meningiomas. Radiat Oncol 9:38. doi:10.1186/1748-717X-9-38

    Article  PubMed  PubMed Central  Google Scholar 

  34. Garzon-Muvdi T, Yang W, Lim M, Brem H, Huang J (2017) Atypical and anaplastic meningioma: outcomes in a population based study. J Neurooncol. doi:10.1007/s11060-017-2436-6

    PubMed  Google Scholar 

Download references

Author information

Author notes

    Authors and Affiliations

    1. Department of Radiation Oncology, Erlangen University Hospital, Universitätsstraße 27, 91054, Erlangen, Germany

      Dorota Lubgan, Sandra Rutzner, Ulrike Lambrecht, Rainer Fietkau & Sabine Semrau

    2. Department of Neurosurgery, Erlangen University Hospital, Erlangen, Germany

      Karl Rössler, Michael Buchfelder & Ilker Eyüpoglu

    Authors
    1. Dorota Lubgan
      View author publications

      You can also search for this author in PubMed Google Scholar

    2. Sandra Rutzner
      View author publications

      You can also search for this author in PubMed Google Scholar

    3. Ulrike Lambrecht
      View author publications

      You can also search for this author in PubMed Google Scholar

    4. Karl Rössler
      View author publications

      You can also search for this author in PubMed Google Scholar

    5. Michael Buchfelder
      View author publications

      You can also search for this author in PubMed Google Scholar

    6. Ilker Eyüpoglu
      View author publications

      You can also search for this author in PubMed Google Scholar

    7. Rainer Fietkau
      View author publications

      You can also search for this author in PubMed Google Scholar

    8. Sabine Semrau
      View author publications

      You can also search for this author in PubMed Google Scholar

    Corresponding author

    Correspondence to Dorota Lubgan.

    Ethics declarations

    Conflict of interest

    All authors state that there are no conflicts of interest.

    Additional information

    Dorota Lubgan and Sandra Rutzner have contributed equally to this work.

    Rights and permissions

    Reprints and permissions

    About this article

    Check for updates. Verify currency and authenticity via CrossMark

    Cite this article

    Lubgan, D., Rutzner, S., Lambrecht, U. et al. Stereotactic radiotherapy as primary definitive or postoperative treatment of intracranial meningioma of WHO grade II and III leads to better disease control than stereotactic radiotherapy of recurrent meningioma. J Neurooncol 134, 407–416 (2017). https://doi.org/10.1007/s11060-017-2540-7

    Download citation

    • Received:

    • Accepted:

    • Published:

    • Issue Date:

    • DOI: https://doi.org/10.1007/s11060-017-2540-7

    Keywords

    Search

    Navigation